Greenleaf Trust Gilead Sciences, Inc. Transaction History

Greenleaf Trust

$10.5 Billion
Q2 2024

A detailed history of Greenleaf Trust transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Greenleaf Trust holds 22,839 shares of GILD stock, worth $1.91 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

22,839

Previous 28,017 18.48%

Holding current value

$1.91 Million

Previous $2.05 Million 23.68%

% of portfolio

0.01%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$63.15 - $72.88 $326,990 - $377,372	-5,178 Reduced 18.48%	22,839 $1.57 Million
Q1 2024 Apr 29, 2024	SELL	$71.58 - $87.29 $892,888 - $1.09 Million	-12,474 Reduced 30.81%	28,017 $2.05 Million
Q4 2023 Jan 31, 2024	BUY	$73.27 - $83.09 $177,972 - $201,825	2,429 Added 6.38%	40,491 $3.28 Million
Q3 2023 Nov 09, 2023	SELL	$73.94 - $80.67 $887 - $968	-12 Reduced 0.03%	38,062 $2.85 Million
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $23,411 - $26,703	-308 Reduced 0.8%	38,074 $2.93 Million
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $181,523 - $206,811	2,348 Added 6.52%	38,382 $3.18 Million
Q4 2022 Jan 25, 2023	BUY	$62.32 - $89.47 $49,856 - $71,576	800 Added 2.27%	36,034 $3.09 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $770,566 - $880,185	12,942 Added 58.06%	35,234 $2.17 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $850,677 - $958,117	14,738 Added 195.1%	22,292 $1.38 Million
Q1 2022 Apr 27, 2022	SELL	$57.92 - $72.58 $350,473 - $439,181	-6,051 Reduced 44.48%	7,554 $449,000
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $72,795 - $82,624	1,122 Added 8.99%	13,605 $988,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $115,073 - $124,151	1,700 Added 15.77%	12,483 $872,000
Q2 2021 Aug 10, 2021	SELL	$63.47 - $69.35 $274,634 - $300,077	-4,327 Reduced 28.64%	10,783 $743,000
Q1 2021 Apr 30, 2021	BUY	$60.0 - $68.46 $322,440 - $367,904	5,374 Added 55.2%	15,110 $977,000
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $253,678 - $289,054	-4,478 Reduced 31.5%	9,736 $567,000
Q3 2020 Oct 30, 2020	SELL	$62.1 - $78.08 $285,597 - $359,089	-4,599 Reduced 24.45%	14,214 $898,000
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $44,272 - $51,408	612 Added 3.36%	18,813 $1.45 Million
Q1 2020 Apr 29, 2020	SELL	$62.63 - $80.22 $306,761 - $392,917	-4,898 Reduced 21.2%	18,201 $1.36 Million
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $48,433 - $53,275	-786 Reduced 3.29%	23,099 $1.5 Million
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $36,880 - $40,710	-590 Reduced 2.41%	23,885 $1.51 Million
Q2 2019 Jul 24, 2019	BUY	$61.87 - $69.38 $80,554 - $90,332	1,302 Added 5.62%	24,475 $1.65 Million
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $75,723 - $84,830	-1,211 Reduced 4.97%	23,173 $1.51 Million
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $184,647 - $240,950	-3,050 Reduced 11.12%	24,384 $1.53 Million
Q3 2018 Oct 29, 2018	BUY	$71.28 - $78.92 $81,187 - $89,889	1,139 Added 4.33%	27,434 $2.12 Million
Q2 2018 Aug 07, 2018	BUY	$64.88 - $75.68 $337,635 - $393,838	5,204 Added 24.67%	26,295 $1.86 Million
Q1 2018 Apr 30, 2018	BUY	$72.84 - $88.8 $20,540 - $25,041	282 Added 1.36%	21,091 $1.59 Million
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $16,720 - $19,627	-235 Reduced 1.12%	20,809 $1.49 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $1.52 Million - $1.8 Million	21,044	21,044 $1.71 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.

Account